MoneyWorks4Me

Lyka Labs - Quaterly Results

20 May 2022 Evaluate
A decent increase of about 55.34% in the turnover to Rs. 276.83 millions was observed for the quarter ended March 2022. The turnover stood at Rs. 178.21 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2022 is Rs. -152.35 millions as compared to Net Profit of Rs. 2.33 millions of corresponding quarter ended March 2021OP of the company witnessed a marginal growth to 122.22 millions from 63.07 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 276.83 178.21 55.34 1643.49 622.63 163.96 1643.49 622.63 163.96
Other Income 6.60 8.48 -22.17 27.20 22.10 23.08 27.20 22.10 23.08
PBIDT 122.22 63.07 93.78 1002.19 166.35 502.46 1002.19 166.35 502.46
Interest 29.10 63.05 -53.85 199.21 255.53 -22.04 199.21 255.53 -22.04
PBDT 65.09 -16.94 -484.24 756.30 -103.47 -830.94 756.30 -103.47 -830.94
Depreciation 91.31 19.50 368.26 153.89 80.50 91.17 153.89 80.50 91.17
PBT -26.22 -36.44 -28.05 602.41 -183.97 -427.45 602.41 -183.97 -427.45
TAX 126.13 -38.77 -425.33 203.38 -39.36 -616.72 203.38 -39.36 -616.72
Deferred Tax 126.13 -38.77 -425.33 203.38 -39.36 -616.72 203.38 -39.36 -616.72
PAT -152.35 2.33 -6638.63 399.03 -144.61 -375.94 399.03 -144.61 -375.94
Equity 286.90 286.90 0.00 286.90 286.90 0.00 286.90 286.90 0.00
PBIDTM(%) 44.15 35.39 24.75 60.98 26.72 128.24 60.98 26.72 128.24
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..